Solid lipid nanoparticles as drug delivery systems
被引:213
作者:
Manjunath, K
论文数: 0引用数: 0
h-index: 0
机构:
Kakatiya Univ, Novel Drug Delivery Syst Lab, Univ Coll Pharmaceut Sci, Warangal, Andhra Pradesh, IndiaKakatiya Univ, Novel Drug Delivery Syst Lab, Univ Coll Pharmaceut Sci, Warangal, Andhra Pradesh, India
Manjunath, K
[1
]
Reddy, JS
论文数: 0引用数: 0
h-index: 0
机构:
Kakatiya Univ, Novel Drug Delivery Syst Lab, Univ Coll Pharmaceut Sci, Warangal, Andhra Pradesh, IndiaKakatiya Univ, Novel Drug Delivery Syst Lab, Univ Coll Pharmaceut Sci, Warangal, Andhra Pradesh, India
Reddy, JS
[1
]
Venkateswarlu, V
论文数: 0引用数: 0
h-index: 0
机构:
Kakatiya Univ, Novel Drug Delivery Syst Lab, Univ Coll Pharmaceut Sci, Warangal, Andhra Pradesh, IndiaKakatiya Univ, Novel Drug Delivery Syst Lab, Univ Coll Pharmaceut Sci, Warangal, Andhra Pradesh, India
Venkateswarlu, V
[1
]
机构:
[1] Kakatiya Univ, Novel Drug Delivery Syst Lab, Univ Coll Pharmaceut Sci, Warangal, Andhra Pradesh, India
来源:
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
|
2005年
/
27卷
/
02期
关键词:
controlled drug release;
formulation factors;
solid lipid nanoparticles;
targeted drug delivery;
D O I:
10.1358/mf.2005.27.2.876286
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
For a decade, trials have been made to utilize solid lipid nanoparticles (SLNs) as alternative drug delivery systems to colloidal drag delivery systema such as lipid emulsions, liposomes, and polymeric nanoparticles. Various lipid matrices, sulfactants, and other excipients used formulation, preparation methods, sterilization and lyophilization of SLNs are discussed in this article. Entrapment efficiency of drug carrier and its effect on physical parameters, drug release, and release mechanisms of various compositions are reviewed and discussed. Important points in characterization and stability of SLNs are outlined. Various in vitro studies carried out by different research groups are mentioned in addition to in vivo evaluation. Exploitation potential of SLNs to administer by various routes of administration are covered. passive and active drug targeting using SLNs are presented. (c) 2005 Prous Science. All rights reserved.